{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:45:15Z","timestamp":1791499515537,"version":"4.3.4"},"reference-count":30,"publisher":"Japan Neurosurgical Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2019]]},"DOI":"10.2176\/nmc.oa.2019-0062","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T22:03:29Z","timestamp":1562364209000},"page":"371-378","source":"Crossref","is-referenced-by-count":9,"title":["Initial Results of Empirical Cryoprecipitate Transfusion in the Treatment of Isolated Severe Traumatic Brain Injury: Use of In-house-produced Cryoprecipitate"],"prefix":"10.2176","volume":"59","author":[{"given":"Keita","family":"SHIBAHASHI","sequence":"first","affiliation":[{"name":"Tertiary Emergency Medical Center, Tokyo Metropolitan Bokutoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeko","family":"NISHIMURA","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Tokyo Metropolitan Bokutoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"SUGIYAMA","sequence":"additional","affiliation":[{"name":"Tertiary Emergency Medical Center, Tokyo Metropolitan Bokutoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"HODA","sequence":"additional","affiliation":[{"name":"Tertiary Emergency Medical Center, Tokyo Metropolitan Bokutoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"HAMABE","sequence":"additional","affiliation":[{"name":"Tertiary Emergency Medical Center, Tokyo Metropolitan Bokutoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"FUJITA","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Tokyo Metropolitan Bokutoh Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"971","reference":[{"key":"1","unstructured":"1) Sauaia A, Moore FA, Moore EE, et al.: Epidemiology of trauma deaths: a reassessment. <i>J Trauma<\/i> 38: 185\u2013193, 1995"},{"key":"2","unstructured":"2) Maegele M, Sch\u00f6chl H, Menovsky T, et al.: Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management. <i>Lancet Neurol<\/i> 16: 630\u2013647, 2017"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Epstein DS, Mitra B, O\u2019Reilly G, Rosenfeld JV, Cameron PA: Acute traumatic coagulopathy in the setting of isolated traumatic brain injury: a systematic review and meta-analysis. <i>Injury<\/i> 45: 819\u2013824, 2014","DOI":"10.1016\/j.injury.2014.01.011"},{"key":"4","unstructured":"4) Murray GD, Butcher I, McHugh GS, et al.: Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT study. <i>J Neurotrauma<\/i> 24: 329\u2013337, 2007"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Talving P, Benfield R, Hadjizacharia P, Inaba K, Chan LS, Demetriades D: Coagulopathy in severe traumatic brain injury: a prospective study. <i>J Trauma<\/i> 66: 55\u201361; discussion 61\u201362, 2009","DOI":"10.1097\/TA.0b013e318190c3c0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Wafaisade A, Lefering R, Tjardes T, et al.: Acute coagulopathy in isolated blunt traumatic brain injury. <i>Neurocrit Care<\/i> 12: 211\u2013219, 2010","DOI":"10.1007\/s12028-009-9281-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Harhangi BS, Kompanje EJ, Leebeek FW, Maas AI: Coagulation disorders after traumatic brain injury. <i>Acta Neurochir<\/i> (<i>Wien<\/i>) 150: 165\u2013175; discussion 175, 2008","DOI":"10.1007\/s00701-007-1475-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Collins PW, Solomon C, Sutor K, et al.: Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate. <i>Br J Anaesth<\/i> 113: 585\u2013595, 2014","DOI":"10.1093\/bja\/aeu086"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Holcomb JB, Fox EE, Zhang X, et al.: Cryoprecipitate use in the PROMMTT study. <i>J Trauma Acute Care Surg<\/i> 75: S31\u2013S39, 2013","DOI":"10.1097\/TA.0b013e31828fa3ed"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Sch\u00f6chl H, Solomon C, Traintinger S, et al.: Thromboelastometric (ROTEM) findings in patients suffering from isolated severe traumatic brain injury. <i>J Neurotrauma<\/i> 28: 2033\u20132041, 2011","DOI":"10.1089\/neu.2010.1744"},{"key":"11","unstructured":"11) Spahn DR, Cerny V, Coats TJ, et al.: Management of bleeding following major trauma: a European guideline. <i>Crit Care<\/i> 11: R17, 2007"},{"key":"12","unstructured":"12) Spahn DR, Bouillon B, Cerny V, et al.: Management of bleeding and coagulopathy following major trauma: an updated European guideline. <i>Crit Care<\/i> 17: R76, 2013"},{"key":"13","unstructured":"13) Rossaint R, Bouillon B, Cerny V, et al.: The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. <i>Crit Care<\/i> 20: 100, 2016"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ohishi K, Matsumoto T, Tanaka Y, et al.: Protocol for the in-house production of cryoprecipitate. <i>Japanese J Transf Cell Ther<\/i> 62: 664\u2013672, 2016","DOI":"10.3925\/jjtc.62.664"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Callum JL, Karkouti K, Lin Y: Cryoprecipitate: the current state of knowledge. <i>Transfus Med Rev<\/i> 23: 177\u2013188, 2009","DOI":"10.1016\/j.tmrv.2009.03.001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Boyd CR, Tolson MA, Copes WS: Evaluating trauma care: the TRISS method. Trauma Score and the Injury Severity Score. <i>J Trauma<\/i> 27: 370\u2013378, 1987","DOI":"10.1097\/00005373-198704000-00005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kanda Y: Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. <i>Bone Marrow Transplant<\/i> 48: 452\u2013458, 2013","DOI":"10.1038\/bmt.2012.244"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Castellino FJ, Chapman MP, Donahue DL, et al.: Traumatic brain injury causes platelet adenosine diphosphate and arachidonic acid receptor inhibition independent of hemorrhagic shock in humans and rats. <i>J Trauma Acute Care Surg<\/i> 76: 1169\u20131176, 2014","DOI":"10.1097\/TA.0000000000000216"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Hoffman M, Monroe DM: Tissue factor in brain is not saturated with factor VIIa: implications for factor VIIa dosing in intracerebral hemorrhage. <i>Stroke<\/i> 40: 2882\u20132884, 2009","DOI":"10.1161\/STROKEAHA.109.555433"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Hoyt DB: A clinical review of bleeding dilemmas in trauma. <i>Semin Hematol<\/i> 41: 40\u201343, 2004","DOI":"10.1053\/j.seminhematol.2003.11.009"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Greuters S, van den Berg A, Franschman G, et al.: Acute and delayed mild coagulopathy are related to outcome in patients with isolated traumatic brain injury. <i>Crit Care<\/i> 15: R2, 2011","DOI":"10.1186\/cc9399"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Keller MS, Fendya DG, Weber TR: Glasgow Coma Scale predicts coagulopathy in pediatric trauma patients. <i>Semin Pediatr Surg<\/i> 10: 12\u201316, 2001","DOI":"10.1053\/spsu.2001.19381"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Hwabejire JO, Imam AM, Jin G, et al.: Differential effects of fresh frozen plasma and normal saline on secondary brain damage in a large animal model of polytrauma, hemorrhage and traumatic brain injury. <i>J Trauma Acute Care Surg<\/i> 75: 968\u2013974; discussion 974\u2013975, 2013","DOI":"10.1097\/TA.0b013e31829a021a"},{"key":"24","unstructured":"24) Jin G, DeMoya MA, Duggan M, et al.: Traumatic brain injury and hemorrhagic shock: evaluation of different resuscitation strategies in a large animal model of combined insults. <i>Shock<\/i> 38: 49\u201356, 2012"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Cushing MM, Fitzgerald MM, Harris RM, Asmis LM, Haas T: Influence of cryoprecipitate, Factor XIII, and fibrinogen concentrate on hyperfibrinolysis. <i>Transfusion<\/i> 57: 2502\u20132510, 2017","DOI":"10.1111\/trf.14259"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Petersen MA, Ryu JK, Akassoglou K: Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics. <i>Nat Rev Neurosci<\/i> 19: 283\u2013301, 2018","DOI":"10.1038\/nrn.2018.13"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Copin JC, Rebetez MM, Turck N, et al.: Matrix metalloproteinase 9 and cellular fibronectin plasma concentrations are predictors of the composite endpoint of length of stay and death in the intensive care unit after severe traumatic brain injury. <i>Scand J Trauma Resusc Emerg Med<\/i> 20: 83, 2012","DOI":"10.1186\/1757-7241-20-83"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Tate CC, Garc\u00eda AJ, LaPlaca MC: Plasma fibronectin is neuroprotective following traumatic brain injury. <i>Exp Neurol<\/i> 207: 13\u201322, 2007","DOI":"10.1016\/j.expneurol.2007.05.008"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Robillard P, Nawej KI, Jochem K: The Quebec hemovigilance system: description and results from the first two years. <i>Transfus Apher Sci<\/i> 31: 111\u2013122, 2004","DOI":"10.1016\/j.transci.2004.07.005"},{"key":"30","unstructured":"30) CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, et al.: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH\u20132): a randomised, placebo-controlled trial. <i>Lancet<\/i> 376: 23\u201332, 2010"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/59\/10\/59_oa.2019-0062\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T03:24:35Z","timestamp":1571455475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/59\/10\/59_oa.2019-0062\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2176\/nmc.oa.2019-0062","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}